Methods are described for inducing cognition and motor function enhancement in patients suffering from Parkinson s disease by administering an effective amount of an Adenosine 2a antagonist. The Adenosine 2a antagonist can optionally be administered in combination with a dopamine precursor such as levodopa or a dopamine receptor agonist